anonymous
Guest
anonymous
Guest
New York (September 12, 2017, 5:32 PM EDT) -- A Massachusetts federal judge on Tuesday set an Oct. 15, 2018, trial date for six former Insys Therapeutics Inc. executives and managers accused of bribing doctors to prescribe a spray version of the opioid fentanyl intended to treat cancer pain, often to patients without cancer.
At a Boston status conference, U.S. District Judge Allison D. Burroughs set the date for an estimated 10-week trial for Michael L. Babich, Alec Burlakoff, Michael J. Gurry, Richard M. Simon, Sunrise Lee and Joseph A. Rowan.
At a Boston status conference, U.S. District Judge Allison D. Burroughs set the date for an estimated 10-week trial for Michael L. Babich, Alec Burlakoff, Michael J. Gurry, Richard M. Simon, Sunrise Lee and Joseph A. Rowan.